Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hologic Inc
(NQ:
HOLX
)
81.57
+1.10 (+1.37%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hologic Inc
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
Analyst Ratings for Hologic
July 18, 2022
Within the last quarter, Hologic (NASDAQ:HOLX) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for Hologic
May 17, 2022
Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter:
Via
Benzinga
Where Hologic Stands With Analysts
October 13, 2022
Over the past 3 months, 5 analysts have published their opinion on Hologic (NASDAQ:HOLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2022 on Monday, October 31, 2022
October 04, 2022
From
Hologic, Inc.
Via
Business Wire
Hologic Rings Nasdaq Opening Bell to Kick Off Breast Cancer Awareness Month
October 03, 2022
From
Hologic, Inc.
Via
Business Wire
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
US Stock Futures Mixed After Recording Losses Last Week; Fed Speakers In Focus
September 26, 2022
Pre-open movers
Via
Benzinga
Amazon, bluebird bio And 3 Stocks To Watch Heading Into Monday
September 26, 2022
With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
More than 1.5 Billion Women Worldwide Lack Essential Health Screenings
September 21, 2022
From
Hologic, Inc.
Via
Business Wire
Hologic to Webcast Presentations at Upcoming Investor Conferences
August 30, 2022
From
Hologic, Inc.
Via
Business Wire
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
Hologic and Mary J. Blige Launch “Good Morning Gorgeous” Sweepstakes as a Wake-up Call to Increase Awareness of the Importance of Preventive Care
August 12, 2022
From
Hologic, Inc.
Via
Business Wire
U.S. Court of Appeals for the Federal Circuit Affirms 2018 Ruling Barring Minerva from Challenging Hologic’s Patent Rights
August 11, 2022
From
Hologic, Inc.
Via
Business Wire
Hologic's Return On Capital Employed Overview
July 28, 2022
Pulled from Benzinga Pro data, Hologic (NASDAQ:HOLX) posted Q3 earnings of $228.40 million, an increase from Q2 of 49.88%. Sales dropped to $1.00 billion, a 30.15% decrease between quarters.
Via
Benzinga
Hologic Announces Financial Results for Third Quarter of Fiscal 2022
July 27, 2022
From
Hologic, Inc.
Via
Business Wire
7 Nasdaq Stocks Trading at a Huge Discount Right Now
July 15, 2022
With the markets performing worse than they have in years, finding Nasdaq stocks trading at a discount is easier than ever.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
July 20, 2022
Upgrades
Via
Benzinga
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2022 on Wednesday, July 27, 2022
July 05, 2022
From
Hologic, Inc.
Via
Business Wire
New Survey Reveals Lack of Knowledge among U.S. Women about Uterine Health, Including Fibroid Symptoms and Treatment Options
July 01, 2022
From
Hologic, Inc.
Via
Business Wire
Augmented Realty and Virtual Reality in Healthcare Market Size, Share, Trends, Industry Analysis, Growth, Business Plan, Opportunities and Forecast 2022-2028
June 02, 2022
Global Augmented Realty and Virtual Reality in Healthcare Market Dynamics 2022-2028, Regional Analysis, Segmentation, Competitive Landscape, COVID-19 Impact, Recent Developments and SWOT Analysis of...
Via
SBWire
Exposures
COVID-19
Medical Imaging Informatics Market New Innovations Trends, Research, Global Share and Growth Factor
May 17, 2022
Medical Imaging Informatics Market New Innovations Trends, Research, Global Share and Growth Factor According to a new report published by Allied Market Research, titled, The medical imaging...
Via
iCrowdNewswire
Hologic Board Member, Sally W. Crawford, Recognized As NACD Directorship 100™ Honoree
May 17, 2022
From
Hologic, Inc.
Via
Business Wire
Laser Hair Removal Service Market Size, Share, Trends & Analysis by Application, Technology, Key Companies, Opportunities and Forecast 2022–2028
May 16, 2022
Intelligence Market Report Publish New Research Report On-“Laser Hair Removal Service 2022 Market Analysis by Key Players, Applications, Growth Trends, Share & Segment Forecast to 2028”
Via
SBWire
CNBC's Final Trades: Charles Schwab And These 3 Medical Stocks
May 12, 2022
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said Charles Schwab Corporation (NYSE: SCHW) is trading at 14 times next year’s earnings.
Via
Benzinga
15 Stocks Moved By Traders on 'Fast Money: Halftime Report'
May 11, 2022
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The...
Via
Benzinga
Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus
May 10, 2022
From
Hologic, Inc.
Via
Business Wire
Hologic to Webcast Presentation at Upcoming Investor Conference
May 04, 2022
From
Hologic, Inc.
Via
Business Wire
Hologic's Return On Capital Employed Overview
April 29, 2022
Pulled from Benzinga Pro data, Hologic (NASDAQ:HOLX) posted Q2 earnings of $455.70 million, an increase from Q1 of 8.71%. Sales dropped to $1.44 billion, a 2.38% decrease between quarters.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.